Literature DB >> 8733532

Minoxidil, hypercoagulability and thromboembolic disease of the lung.

S G Keohane1, M Edmunds, J Holton, J D Swales.   

Abstract

Minoxidil is a potent antihypertensive agent used in the treatment of resistant hypertension. A case is presented which illustrates a probably fatal interaction between minoxidil and a coagulation disorder.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8733532      PMCID： PMC2398428          DOI： 10.1136/pgmj.72.846.229

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  5 in total

1.  Hemodynamic effects of vasodilators and long-term response in heart failure.

Authors:  J A Franciosa; W B Dunkman; C L Leddy
Journal:  J Am Coll Cardiol       Date:  1984-06       Impact factor: 24.094

2.  Minoxidil: right atrial cardiac pathology in animals and in man.

Authors:  J T Sobota; W B Martin; R G Carlson; E S Feenstra
Journal:  Circulation       Date:  1980-08       Impact factor: 29.690

3.  Uridine kinase inhibition is involved in the vasodilator effects of minoxidil in the rat.

Authors:  G Macdonald; T Walker; R Assef; K Duggan
Journal:  Clin Exp Pharmacol Physiol       Date:  1990-04       Impact factor: 2.557

Review 4.  Review of cardiovascular findings in humans treated with minoxidil.

Authors:  J T Sobota
Journal:  Toxicol Pathol       Date:  1989       Impact factor: 1.902

5.  Influence of minoxidil on myocardial hemodynamics, regional blood flow, and morphology in beagle dogs.

Authors:  G K Jett; E H Herman; M Jones; V J Ferrans; R E Clark
Journal:  Cardiovasc Drugs Ther       Date:  1988-03       Impact factor: 3.727
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.